We are live on ! Find out more
MA

Marshwinds Advisory Portfolio holdings

AUM $187M
1-Year Est. Return 1.79%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
-1.79%
3 Year Est. Return
+32.92%
5 Year Est. Return
+52.83%
10 Year Est. Return
AUM
$205M
AUM Growth
+$10.5M
Cap. Flow
+$1.2M
Cap. Flow %
0.59%
Top 10 Hldgs %
25.18%
Holding
143
New
6
Increased
32
Reduced
62
Closed
1

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$1.24M
2
XOM icon
ExxonMobil
XOM
+$344K
3
SU icon
Suncor Energy
SU
+$314K
4
EMC
EMC CORPORATION
EMC
+$216K
5
FLS icon
Flowserve
FLS
+$211K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$123K
2
ORCL icon
Oracle
ORCL
+$95.8K
3
USB icon
US Bancorp
USB
+$91.6K
4
STJ
St Jude Medical
STJ
+$85.6K
5
MDLZ icon
Mondelez International
MDLZ
+$69.6K

Sector Composition

Rank Sector Weight
1 Consumer Staples 17.25%
2 Healthcare 16.76%
3 Industrials 16.76%
4 Technology 14.65%
5 Communication Services 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
1
Coca-Cola
KO
$377B
$7.49M 3.65%
165,209
-1,072
-0.6% -$48.4K
T
2
DELISTED
A T & T CORP (NEW)
T
$6.56M 3.19%
151,826
-1,296
-0.8% -$56K
GE icon
3
GE Aerospace
GE
$375B
$5.81M 2.83%
38,492
-237
-0.6% -$34.6K
MDLZ icon
4
Mondelez International
MDLZ
$79.6B
$5.33M 2.59%
117,047
-1,598
-1% -$69.6K
ORCL icon
5
Oracle
ORCL
$371B
$4.87M 2.37%
118,993
-2,400
-2% -$95.8K
XOM icon
6
ExxonMobil
XOM
$641B
$4.55M 2.22%
48,580
+3,887
+9% +$344K
PFE icon
7
Pfizer
PFE
$143B
$4.53M 2.2%
135,486
-765
-0.6% -$24.4K
MSFT icon
8
Microsoft
MSFT
$3.44T
$4.33M 2.11%
84,570
-736
-0.9% -$38.2K
AMGN icon
9
Amgen
AMGN
$208B
$4.22M 2.06%
27,740
-790
-3% -$123K
PG icon
10
Procter & Gamble
PG
$335B
$4.04M 1.97%
47,740
+318
+0.7% +$26.1K
DD
11
DELISTED
Du Pont De Nemours E I
DD
$4.02M 1.96%
62,073
-923
-1% -$60.6K
MRK icon
12
Merck
MRK
$322B
$3.91M 1.9%
71,113
-799
-1% -$42.5K
IBM icon
13
IBM
IBM
$209B
$3.86M 1.88%
26,632
+78
+0.3% +$11.2K
KHC icon
14
Kraft Heinz
KHC
$30.8B
$3.74M 1.82%
42,226
-98
-0.2% -$8.06K
MMM icon
15
3M
MMM
$90.8B
$3.62M 1.76%
24,734
-238
-1% -$33.6K
CSCO icon
16
Cisco
CSCO
$457B
$3.42M 1.67%
119,248
+22
+0% +$618
NOC icon
17
Northrop Grumman
NOC
$77.2B
$3.4M 1.65%
15,278
-50
-0.3% -$10.5K
INTC icon
18
Intel
INTC
$468B
$3.34M 1.63%
101,902
-1,598
-2% -$50.1K
EMR icon
19
Emerson Electric
EMR
$84.2B
$3.33M 1.62%
63,937
-249
-0.4% -$13.2K
LLY icon
20
Eli Lilly
LLY
$1.02T
$3.32M 1.62%
42,140
-439
-1% -$33K
STJ
21
DELISTED
St Jude Medical
STJ
$3.27M 1.59%
41,965
-1,200
-3% -$85.6K
SO icon
22
Southern Company
SO
$109B
$3.26M 1.59%
60,759
+503
+0.8% +$25.3K
BMY icon
23
Bristol-Myers Squibb
BMY
$133B
$3.22M 1.57%
43,767
-600
-1% -$42.4K
TR icon
24
Tootsie Roll Industries
TR
$2.95B
$3.18M 1.55%
110,880
+2,704
+2% +$72.1K
INTU icon
25
Intuit
INTU
$86.5B
$3.12M 1.52%
27,980

Similar funds

Marshwinds Advisory's Q2 2016 Portfolio in Review

As of Q2 2016, Marshwinds Advisory held 143 positions worth $205M, up 5.4% from $195M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 4.9%. Marshwinds Advisory opened 6 new positions and exited 1, leaving the 143-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • Marshwinds Advisory's largest Q2 2016 buy was SLB Ltd: 16,121 shares worth $1.27M.
  • Marshwinds Advisory added most to ExxonMobil in Q2 2016, an estimated $344K increase.
  • Marshwinds Advisory's biggest Q2 2016 reduction was Amgen, cutting an estimated $123K.
  • Marshwinds Advisory's ten largest holdings make up 25% of its $205M portfolio in Q2 2016.
  • Marshwinds Advisory opened 6 new positions and closed 1 in Q2 2016.
  • Marshwinds Advisory's portfolio value rose 5.4% quarter-over-quarter to $205M.

Based on Marshwinds Advisory's 13F filing for Q2 2016, filed 6 Jul 2016.